Compound file

SLU-PP-332

SLU-PP-332 is a synthetic ERR pan-agonist developed at Saint Louis University that functions as an 'exercise mimetic' in preclinical models. Animal studies show significant metabolic benefits including 12% weight loss, 70% improved endurance, and enhanced mitochondrial biogenesis, but no human clinical trials have been conducted. Safety profile appears favorable in rodent and canine models, though human safety is completely unknown.